Cariprazine Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: Reagila, ATC: N05AX15, Vraylar

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

AbbVie1
Aalborg University Hospital1

Indications

Depression2
Depression Bipolar1
Bipolar I Disorder1

Other1 trial

Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)

Phase 4

Bentonville, Arkansas1 trial

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Pillar Clinical Research /ID# 226504

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.